235
Views
52
CrossRef citations to date
0
Altmetric
Original Research

Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles

, , , , , , & show all
Pages 957-973 | Published online: 14 Feb 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Tania Mariastella Caputo, Giovannina Barisciano, Chiara Mulè, Angela Maria Cusano, Anna Aliberti, Livio Muccillo, Vittorio Colantuoni, Lina Sabatino & Andrea Cusano. (2023) Development of High-Loading Trastuzumab PLGA Nanoparticles: A Powerful Tool Against HER2 Positive Breast Cancer Cells. International Journal of Nanomedicine 18, pages 6999-7020.
Read now
Buyankhishig Dorjsuren, Birendra Chaurasiya, Zixuan Ye, Yanyan Liu, Wei Li, Chaoyang Wang, Di Shi, Colin E Evans, Thomas J Webster & Yan Shen. (2020) Cetuximab-Coated Thermo-Sensitive Liposomes Loaded with Magnetic Nanoparticles and Doxorubicin for Targeted EGFR-Expressing Breast Cancer Combined Therapy. International Journal of Nanomedicine 15, pages 8201-8215.
Read now
Kyungeun Kim & Dongwoo Khang. (2020) Past, Present, and Future of Anticancer Nanomedicine. International Journal of Nanomedicine 15, pages 5719-5743.
Read now
Wen Bao, Ran Liu, Guohua Xia, Fei Wang & Baoan Chen. (2019) Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation. Drug Design, Development and Therapy 13, pages 1107-1115.
Read now
Xiaoxue Zhang, Yinyan Li, Minjie Wei, Chang Liu, Tao Yu & Jun Yang. (2019) Cetuximab-modified silica nanoparticle loaded with ICG for tumor-targeted combinational therapy of breast cancer. Drug Delivery 26:1, pages 129-136.
Read now

Articles from other publishers (47)

Niloufar Rashidi, Majid Davidson, Vasso Apostolopoulos & Kulmira Nurgali. (2024) Nanoparticles in cancer diagnosis and treatment: Progress, challenges, and opportunities. Journal of Drug Delivery Science and Technology 95, pages 105599.
Crossref
Arezoo Gholami, Hamidreza Abdouss, Mehrab Pourmadadi, Majid Abdouss, Abbas Rahdar & Sadanand Pandey. (2024) A comprehensive perspective of trastuzumab-based delivery systems for breast cancer treatment. Journal of Drug Delivery Science and Technology 95, pages 105592.
Crossref
Jiashuai Wu, Xiaopeng Wang, Yunduan Wang, Zhe Xun & Shuo Li. (2024) Application of PLGA in Tumor Immunotherapy. Polymers 16:9, pages 1253.
Crossref
Levi Collin Nelemans, Vinicio Alejandro Melo, Matej Buzgo, Edwin Bremer & Aiva Simaite. (2024) Antibody desolvation with sodium chloride and acetonitrile generates bioactive protein nanoparticles. PLOS ONE 19:3, pages e0300416.
Crossref
Mohammad Azhar Aziz & Syed Hammad Ali. 2024. Cancer Therapy. Cancer Therapy 105 129 .
Polina A. Kotelnikova, Victoria O. Shipunova & Sergey M. Deyev. (2023) Targeted PLGA–Chitosan Nanoparticles for NIR-Triggered Phototherapy and Imaging of HER2-Positive Tumors. Pharmaceutics 16:1, pages 9.
Crossref
Ayaka Hanaki, Koki Ogawa, Tatsuaki Tagami & Tetsuya Ozeki. (2023) Fabrication and Characterization of Antibody-Loaded Cationic Porous PLGA Microparticles for Sustained Antibody Release. The AAPS Journal 25:6.
Crossref
Xiangyi Kong, Yihang Qi, Xiangyu Wang, Rui Jiang, Jing Wang, Yi Fang, Jidong Gao & Kuo Chu Hwang. (2023) Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer. Progress in Materials Science 134, pages 101070.
Crossref
Shadma Wahab, Mohammed Ghazwani, Umme Hani, Abdulrahim R. Hakami, Abdulrahman A. Almehizia, Wasim Ahmad, Mohammad Zaki Ahmad, Prawez Alam & Sivakumar Annadurai. (2023) Nanomaterials-Based Novel Immune Strategies in Clinical Translation for Cancer Therapy. Molecules 28:3, pages 1216.
Crossref
Adelaide Iervolino, Luigi Spadafora, Cristiano Spadaccio, Valentina Iervolino, Giuseppe Biondi Zoccai & Felicita Andreotti. (2022) Myocardial Cell Preservation from Potential Cardiotoxic Drugs: The Role of Nanotechnologies. Pharmaceutics 15:1, pages 87.
Crossref
Biagio Todaro & Melissa Santi. (2022) Characterization and Functionalization Approaches for the Study of Polymeric Nanoparticles: The State of the Art in Italian Research. Micro 3:1, pages 9-21.
Crossref
Zerong Pei, Shuting Chen, Liqin Ding, Jingbo Liu, Xinyi Cui, Fengyun Li & Feng Qiu. (2022) Current perspectives and trend of nanomedicine in cancer: A review and bibliometric analysis. Journal of Controlled Release 352, pages 211-241.
Crossref
Emre Ozgenc, Merve Karpuz, Ege Arzuk, Marta Gonzalez-Alvarez, Marival Bermejo Sanz, Evren Gundogdu & Isabel Gonzalez-Alvarez. (2022) Radiolabeled Trastuzumab Solid Lipid Nanoparticles for Breast Cancer Cell: in Vitro and in Vivo Studies. ACS Omega 7:34, pages 30015-30027.
Crossref
Aisha Shigna Nadukkandy, Eshani Ganjoo, Ankit Singh & Lekha Dinesh Kumar. (2022) Tracing New Landscapes in the Arena of Nanoparticle-Based Cancer Immunotherapy. Frontiers in Nanotechnology 4.
Crossref
Shun‐Yu Wu, Fu‐Gen Wu & Xiaoyuan Chen. (2022) Antibody‐Incorporated Nanomedicines for Cancer Therapy. Advanced Materials 34:24.
Crossref
Lili Zhou, Manshu Zou, Yilin Xu, Peng Lin, Chang Lei & Xinhua Xia. (2022) Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics. Frontiers in Oncology 12.
Crossref
Mirina Sakhi, Abad Khan, Zafar Iqbal, Ismail Khan, Abida Raza, Asmat Ullah, Fazli Nasir & Saeed Ahmad Khan. (2022) Design and Characterization of Paclitaxel-Loaded Polymeric Nanoparticles Decorated With Trastuzumab for the Effective Treatment of Breast Cancer. Frontiers in Pharmacology 13.
Crossref
Simona-Ruxandra Volovat, Corina Lupascu Ursulescu, Liliana Gheorghe Moisii, Constantin Volovat, Diana Boboc, Dragos Scripcariu, Florin Amurariti, Cipriana Stefanescu, Cati Raluca Stolniceanu, Maricel Agop, Cristian Lungulescu & Cristian Constantin Volovat. (2022) The Landscape of Nanovectors for Modulation in Cancer Immunotherapy. Pharmaceutics 14:2, pages 397.
Crossref
Lihong Sun, Jinxia Zhang, Menghong Xu, Lulu Zhang, Qingshuang Tang, Jing Chen, Ming Gong, Suhui Sun, Huiyu Ge, Shumin Wang, Xiaolong Liang & Ligang Cui. (2021) Ultrasound Microbubbles Mediated Sonosensitizer and Antibody Co-delivery for Highly Efficient Synergistic Therapy on HER2-Positive Gastric Cancer. ACS Applied Materials & Interfaces 14:1, pages 452-463.
Crossref
Constantin Volovat, Simona-Ruxandra Volovat & Maricel Agop. 2022. Immunomodulators and Human Health. Immunomodulators and Human Health 125 186 .
Xiangyu Meng, Yunfeng Lei, Xuezhong Zhang, Kai Sun, Liming Zhang & Zhifei Wang. (2021) Cancer immunotherapy: Classification, therapeutic mechanisms, and nanomaterial-based synergistic therapy. Applied Materials Today 24, pages 101149.
Crossref
Salma B. Abdelbaky, Mayar Tarek Ibrahim, Hebatallah Samy, Menatalla Mohamed, Hebatallah Mohamed, Mahmoud Mustafa, Moustafa M. Abdelaziz, M. Laird Forrest & Islam A. Khalil. (2021) Cancer immunotherapy from biology to nanomedicine. Journal of Controlled Release 336, pages 410-432.
Crossref
Hernán Cortés, Héctor Hernández-Parra, Sergio A. Bernal-Chávez, María L. Del Prado-Audelo, Isaac H. Caballero-Florán, Fabiola V. Borbolla-Jiménez, Maykel González-Torres, Jonathan J. Magaña & Gerardo Leyva-Gómez. (2021) Non-Ionic Surfactants for Stabilization of Polymeric Nanoparticles for Biomedical Uses. Materials 14:12, pages 3197.
Crossref
Safiye Akkın, Gamze Varan & Erem Bilensoy. (2021) A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers. Molecules 26:11, pages 3382.
Crossref
Noé Escareño, Natalia Hassan, Marcelo J. Kogan, Josué Juárez, Antonio Topete & Adrián Daneri-Navarro. (2021) Microfluidics-assisted conjugation of chitosan-coated polymeric nanoparticles with antibodies: Significance in drug release, uptake, and cytotoxicity in breast cancer cells. Journal of Colloid and Interface Science 591, pages 440-450.
Crossref
Qiu-Ping Feng, Yu-Ting Zhu, Yi-Zhen Yuan, Wen-Jie Li, Hao-Han Yu, Meng-Yuan Hu, Su-Yun Xiang & Shu-Qin Yu. (2021) Oral administration co-delivery nanoparticles of docetaxel and bevacizumab for improving intestinal absorption and enhancing anticancer activity. Materials Science and Engineering: C 124, pages 112039.
Crossref
Balney Rajitha, Rama Rao Malla, Ramakrishna Vadde, Prameswari Kasa, Ganji Lakshmi Vara Prasad, Batoul Farran, Seema Kumari, Eluri Pavitra, Mohammad Amjad Kamal, Ganji Seeta Rama Raju, Sujatha Peela & Ganji Purnachandra Nagaraju. (2021) Horizons of nanotechnology applications in female specific cancers. Seminars in Cancer Biology 69, pages 376-390.
Crossref
Xiangyi Kong, Ran Cheng, Jing Wang, Yi Fang & Kuo Chu Hwang. (2021) Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications. Nano Today 36, pages 101004.
Crossref
Amanda Letícia Polli Silvestre, Joáo Augusto Oshiro-Júnior, Camila Garcia, Bruna Ortolani Turco, Joandra Maísa da Silva Leite, Bolivar Ponciano Goulart de Lima Damasceno, Jonas Corsino Maduro Soares & Marlus Chorilli. (2020) Monoclonal Antibodies Carried in Drug Delivery Nanosystems as a Strategy for Cancer Treatment. Current Medicinal Chemistry 28:2, pages 401-418.
Crossref
Rany Rotem, Angelo Micale, Maria Antonietta Rizzuto, Martina Migliavacca, Marco Giustra, Lucia Salvioni, Federico Tasin, Davide Prosperi & Miriam Colombo. (2020) Modeling the interaction of amphiphilic polymer nanoparticles with biomembranes to Guide rational design of drug delivery systems. Colloids and Surfaces B: Biointerfaces 196, pages 111366.
Crossref
Mohammed Rahman, Rachita Lahri, Syed Ahsan, Maya Thanou & Panagiotis Kosmas. (2020) Assessing Changes in Dielectric Properties Due to Nanomaterials Using a Two-Port Microwave System. Sensors 20:21, pages 6228.
Crossref
Jingxian Yang, Chunhui Wang, Shuo Shi & Chunyan Dong. (2020) Nanotechnologies for enhancing cancer immunotherapy. Nano Research 13:10, pages 2595-2616.
Crossref
Jooneon Park, Paul L. Chariou & Nicole F. Steinmetz. (2020) Site-Specific Antibody Conjugation Strategy to Functionalize Virus-Based Nanoparticles. Bioconjugate Chemistry 31:5, pages 1408-1416.
Crossref
Indra Hering, Elke Eilebrecht, Michael J. Parnham, Nazende Günday-Türeli, Akif Emre Türeli, Marc Weiler, Christoph Schäfers, Martina Fenske & Matthias G. Wacker. (2020) Evaluation of potential environmental toxicity of polymeric nanomaterials and surfactants. Environmental Toxicology and Pharmacology 76, pages 103353.
Crossref
Nermin E. Eleraky, Nitin K. Swarnakar, Dina F. Mohamed, Mohamed A. Attia & Giovanni M. Pauletti. (2020) Permeation-Enhancing Nanoparticle Formulation to Enable Oral Absorption of Enoxaparin. AAPS PharmSciTech 21:3.
Crossref
Nora Bloise, Alessio Massironi, Cristina Della Pina, Jenny Alongi, Stella Siciliani, Amedea Manfredi, Marco Biggiogera, Michele Rossi, Paolo Ferruti, Elisabetta Ranucci & Livia Visai. (2020) Extra-Small Gold Nanospheres Decorated With a Thiol Functionalized Biodegradable and Biocompatible Linear Polyamidoamine as Nanovectors of Anticancer Molecules. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Yajie Zhang, Miguel García-Gabilondo, Alba Grayston, Irene V. J. Feiner, Irene Anton-Sales, Rodrigo A. Loiola, Jordi Llop, Pedro Ramos-Cabrer, Ignasi Barba, David Garcia-Dorado, Fabien Gosselet, Anna Rosell & Anna Roig. (2020) PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities. Nanoscale 12:8, pages 4988-5002.
Crossref
Karol Yesenia Hernández-Giottonini, Rosalva Josefina Rodríguez-Córdova, Cindy Alejandra Gutiérrez-Valenzuela, Omar Peñuñuri-Miranda, Paul Zavala-Rivera, Patricia Guerrero-Germán & Armando Lucero-Acuña. (2020) PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters. RSC Advances 10:8, pages 4218-4231.
Crossref
Ju Zhang, Panpan Liu, Zirui Zhang, Jing Han, Xu Yang, Aimin Wang & Xiaochun Zhang. (2020) Apatinib-loaded nanoparticles inhibit tumor growth and angiogenesis in a model of melanoma. Biochemical and Biophysical Research Communications 521:2, pages 296-302.
Crossref
Lucia Morelli, Sara Gimondi, Marta Sevieri, Lucia Salvioni, Maria Guizzetti, Barbara Colzani, Luca Palugan, Anastasia Foppoli, Laura Talamini, Lavinia Morosi, Massimo Zucchetti, Martina Bruna Violatto, Luca Russo, Mario Salmona, Davide Prosperi, Miriam Colombo & Paolo Bigini. (2019) Monitoring the Fate of Orally Administered PLGA Nanoformulation for Local Delivery of Therapeutic Drugs. Pharmaceutics 11:12, pages 658.
Crossref
E. Krasniqi, G. Barchiesi, L. Pizzuti, M. Mazzotta, A. Venuti, M. Maugeri-Saccà, G. Sanguineti, G. Massimiani, D. Sergi, S. Carpano, P. Marchetti, S. Tomao, T. Gamucci, R. De Maria, F. Tomao, C. Natoli, N. Tinari, G. Ciliberto, M. Barba & P. Vici. (2019) Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives. Journal of Hematology & Oncology 12:1.
Crossref
In-Bo Han, Devang K. Thakor, Alexander E. Ropper, Dou Yu, Lei Wang, Serdar Kabatas, Xiang Zeng, Soo-Woo Kim, Ross D. Zafonte & Yang D. Teng. (2019) Physical impacts of PLGA scaffolding on hMSCs: Recovery neurobiology insight for implant design to treat spinal cord injury. Experimental Neurology 320, pages 112980.
Crossref
Narsireddy Amreddy, Anish Babu, Anupama Munshi & Rajagopal Ramesh. 2019. Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics. Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics 81 99 .
Suchithra Poilil Surendran, Myeong Ju Moon, Rayoung Park & Yong Yeon Jeong. (2018) Bioactive Nanoparticles for Cancer Immunotherapy. International Journal of Molecular Sciences 19:12, pages 3877.
Crossref
Miriam Colombo, Maria Antonietta Rizzuto, Chiara Pacini, Laura Pandolfi, Arianna Bonizzi, Marta Truffi, Matteo Monieri, Francesco Catrambone, Marco Giustra, Stefania Garbujo, Luisa Fiandra, Fabio Corsi, Davide Prosperi & Serena Mazzucchelli. (2018) Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer. Bioconjugate Chemistry 29:11, pages 3817-3832.
Crossref
Madhu Chaturvedi, Justin Schilling, Alexandre Beautrait, Michel Bouvier, Jeffrey L. Benovic & Arun K. Shukla. (2018) Emerging Paradigm of Intracellular Targeting of G Protein-Coupled Receptors. Trends in Biochemical Sciences 43:7, pages 533-546.
Crossref
C. Tilden HaganIVIV, Yusra B. Medik & Andrew Z. Wang. 2018. Cancer Nanotechnology. Cancer Nanotechnology 35 56 .